VCG
Vantage Consulting Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,379
| Closed | -$237K | – | 7 |
|
|
2024
Q2 | $237K | Buy |
1,379
+49
| +4% | +$8.4K | 0.18% | 120 |
|
|
2024
Q1 | $242K | Sell |
1,330
-237
| -15% | -$43.2K | 0.15% | 137 |
|
|
2023
Q4 | $243K | Buy |
1,567
+9
| +0.6% | +$1.4K | 0.16% | 135 |
|
|
2023
Q3 | $232K | Sell |
1,558
-109
| -7% | -$16.2K | 0.16% | 139 |
|
|
2023
Q2 | $225K | Buy |
1,667
+67
| +4% | +$9.03K | 0.13% | 177 |
|
|
2023
Q1 | $255K | Buy |
1,600
+114
| +8% | +$18.2K | 0.14% | 142 |
|
|
2022
Q4 | $240K | Sell |
1,486
-332
| -18% | -$53.7K | 0.14% | 145 |
|
|
2022
Q3 | $244K | Buy |
1,818
+144
| +9% | +$19.3K | 0.14% | 127 |
|
|
2022
Q2 | $256K | Buy |
1,674
+135
| +9% | +$20.6K | 0.14% | 112 |
|
|
2022
Q1 | $249K | Sell |
1,539
-533
| -26% | -$86.2K | 0.1% | 142 |
|
|
2021
Q4 | $281K | Sell |
2,072
-205
| -9% | -$27.8K | 0.08% | 128 |
|
|
2021
Q3 | $246K | Buy |
2,277
+319
| +16% | +$34.5K | 0.05% | 133 |
|
|
2021
Q2 | $221K | Buy |
+1,958
| New | +$221K | 0.04% | 178 |
|
|
2021
Q1 | – | Sell |
-687
| Closed | -$74K | – | 106 |
|
|
2020
Q4 | $74K | Buy |
+687
| New | +$74K | 0.01% | 280 |
|